Proteins and Peptides

22 Aug 2007 Sinobiomed Completes Evaluation of Preclinical Safety Studies on World's First Recombinant Human Kallikrein
22 Aug 2007 SemBioSys Updates Apo AI Development Program
22 Aug 2007 Artisan Pharma, Inc. launches Phase 2b trial of ART-123 for the treatment of DIC in sepsis
21 Aug 2007 Solvay Pharmaceuticals, Inc. Receives Approvable Letter from FDA with Respect to New Drug Application for CREON(R)
21 Aug 2007 Liraglutide improves glucose control and lowers body weight in two phase 3 studies comprising more than 2,000 patients
21 Aug 2007 Wyeth Receives Approval from European Medicines Agency for New BeneFIX Features
21 Aug 2007 Pharming reports positive results in European placebo-controlled trial Of Rhucin(R) in hereditary angioedema
17 Aug 2007 Jerini Receives EMEA Filing Acceptance of its Marketing Application for Icatibant in the Treatment of Hereditary Angioedema
15 Aug 2007 Oramed Pharmaceuticals Successfully Completes Phase 1A Trials
15 Aug 2007 Altus Pharmaceuticals’ ALTU-237 Enters Phase I Clinical Trial for the Treatment of Hyperoxalurias and the Potential Prevention of Kidney Stone Formation
14 Aug 2007 BioMarin partner AnGes MG, Inc. submits BLA to Japanese Ministry of Health
14 Aug 2007 BioDiem completes treatment in phase I/II study of eye drug BDM-E: Results due November 07
11 Aug 2007 Unigene in-licenses potential therapies for inflammation and cardiovascular disease from University of London
10 Aug 2007 Protalix BioTherapeutics signs agreement to license acetylcholinestrase development technology
09 Aug 2007 Positive Phase 1b transdermal insulin clincial trial results
09 Aug 2007 The Medicines Company submits Angiomax(R) (Bivalirudin) sNDA to expand label to include ACUITY data
09 Aug 2007 Nutra Pharma Announces Positive Results of ReceptoPharm Pain Study
09 Aug 2007 Tercica Receives Marketing Approval for Increlex in the European Union
08 Aug 2007 MicroDose announces positive results from the QDose inhaled insulin glucose clamp study
07 Aug 2007 First patient enrolled into ATryn (R) Phase II study in DIC indication
04 Aug 2007 Patients treated with Betaferon(R) after first MS attack experienced significant delay in disability progession
03 Aug 2007 Unigene Initiates Oral Calcitonin Clinical Study in Humans
02 Aug 2007 Lev Pharmaceuticals Submits Biologics License Application for Cinryze(TM)
01 Aug 2007 Laureate Pharma Announces Agreement with Enobia Pharma, Inc.
31 Jul 2007 Cadence Pharmaceuticals announces agreement with fda on increased enrolment in Phase III clinical trial of Omigard (TM)

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top